Medicinal product name Methotrexat-Ebewe 5 mg tablets
Pharmaceutical form Tablet
Strength 5 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Package leafletPDF 11-10-2023 (Oct 12, 2023)
Risk minimisation measuresIzglītojošie materiāli ārstam Izglītojošie materiāli ārstam
Izglītojošie materiāli farmaceitam Izglītojošie materiāli farmaceitam
Izglītojošie materiāli pacientam Izglītojošie materiāli pacientam
ATC code L01BA01 Antineoplastic agents
Information for Marketing authorisation holdersView

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N50
(5 mg)
Polypropylene 14.04  I001326-01 Outer Outer Aug 27, 2021
Inner Inner Aug 27, 2021

Registration information

Authorisations for distribution of parallel imported medicines no. I001326
Authorisation for distribution of parallel imported medicines revoked Jan 1, 2024
Permitted to distribute until Jul 1, 2024
Marketing authorisation holder, country Ebewe Pharma Ges.m.b.H Nfg.KG, Austria
Parallel importer, country SIA "ABC Pharma", Latvia
Country of medicines exporter Poland